Hope Medicine (HopeMed) is a science-driven, patient-centric, clinical-stage biotech company with research and development bases in major innovation hubs in China. The company was established on the foundation of deep understanding of disease biology and translational medicine, and decades of scientific research in the laboratory of the founder, Professor Rui-Ping Xiao, at Peking University. With a management team of highly accomplished industry veterans combining entrepreneurship and global pharma experience, HopeMed is committed to the discovery, development, and commercialization of innovative, safe, effective, affordable medicines for large, underserved patient populations. Strategically, we are building a robust pipeline in the field of endocrine, cardiovascular and metabolic diseases, with a special focus on women’s health, through internal R&D capabilities, access to external technology platforms to enable a variety of molecular modalities, as well as in-license of complementary and differentiated assets to address unmet medical needs.
Headquarters
Building Y1, No.112 Liangxiu Road,Pudong
h_icon2.svg
Public Relationship
pr@hopemedinc.com
h_icon3.svg
Talent Acquisition
hopemed.hr@hopemedinc.com
h_icon3-108.svg
Business Development
bd@hopemedinc.com
Shall not be reproduced without permission:ZHLL.COM » Hope Medicine Inc.